Table 1 Clinical characteristics and treatment outcomes of our patients
Patient | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|
Type of OMD | Jaw Opening | Jaw Opening | Jaw Closure | Jaw Opening | Jaw Opening |
Etiology | Idiopathic | Idiopathic | Idiopathic | Idiopathic | Tardive |
Age | 58 | 48 | 32 | 57 | 50 |
Gender | Male | Female | Male | Female | Female |
Duration | 5y | 1y | 2y | 10y | 1y |
Follow-up | 3y | 2y | 1.5y | 8y | 1y |
Other Dystonia | No | Blepharospasm | No | No | No |
Orofaciolingual involvement | No | Tongue protrusion | No | Tongue dyskinesias, bruxism | Facial grimacing, tongue dyskinesia, lip biting |
Botulinum toxin/sessions | Yes/9 | Yes/4 | Yes/4 | Yes/1 | Yes/2 |
Site(s) | Lateral pterygoids 75 u/side | Lateral pterygoids 50 u/side | Masseters 50 u/side | Lateral pterygoids 25 u/side | Lateral. pterygoids |
Total | 150 | 100 | 100 | 50 | N/A |
Response (GIS) to Botulinum toxin A injections | Marked | No | Moderate | No | No |
Duration of response | 3 months | ---- | 3 months | ----- | ---- |
Antidystonic medications (response) | No | trihexyphenidyl lorazepam, tetrabenazine, (marked) | No | tetrabenazine, gabapentine (marked) | No |
Weight loss | No | 15 lbs | no | 15 lbs | 13 lbs |
Weight gain after treatment | ----- | 15 lbs | ----- | 10 lbs | N/A |